Johnson & Johnson - Apr 9, 2024 Form 3 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
10%+ Owner
Signature
Johnson & Johnson By: /s/ Marc Larkins, Secretary
Stock symbol
CTNM
Transactions as of
Apr 9, 2024
Transactions value $
$0
Form type
3
Date filed
4/10/2024, 05:05 PM
Previous filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTNM Class A Common Stock 1.98M Apr 9, 2024 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities reported as indirectly beneficially owned by Johnson & Johnson are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of Johnson & Johnson.